0
June 20, 2011, Vol 147, No. 6 >

Full Content is available to subscribers

Subscribe/Learn More
Off-Center Fold | June 20, 2011

Papulopustular Eruptions in a 32-Year-Old Woman After Lung Cancer Treatment—Diagnosis

Arch Dermatol. 2011;147(6):735-740. doi:10.1001/archdermatol.2011.127-b.
Text Size: A A A
Published online
Article
References
Comments

Extract

REFERENCES
1 +
Ciardiello  FTortora  G EGFR antagonists in cancer treatment. N Engl J Med 2008;358 (11) 1160- 1174
PubMed
2 +
Agero  ALDusza  SWBenvenuto-Andrade  CBusam  KJMyskowski  PHalpern  AC Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol 2006;55 (4) 657- 670
PubMed
3 +
Jacot  WBessis  DJorda  E  et al.  Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours. Br J Dermatol 2004;151 (1) 238- 241
PubMed
4 +
Lacouture  MELai  SE The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to EGFR inhibitors) syndrome. Br J Dermatol 2006;155 (4) 852- 854
PubMed
5 +
Pérez-Soler  RChachoua  AHammond  LA  et al.  Determinants of tumor response and survival with erlotinib in patients with non–small-cell lung cancer. J Clin Oncol 2004;22 (16) 3238- 3247
PubMed
6 +
Dainichi  TTanaka  MTsuruta  NFurue  MNoda  K Development of multiple paronychia and periungual granulation in patients treated with gefitinib, an inhibitor of epidermal growth factor receptor. Dermatology 2003;207 (3) 324- 325
PubMed
7 +
Pascual  JCBañuls  JBelinchon  IBlanes  MMassuti  B Trichomegaly following treatment with gefitinib (ZD1839). Br J Dermatol 2004;151 (5) 1111- 1112
PubMed
8 +
Boone  SLRademaker  ALiu  DPfeiffer  CMauro  DJLacouture  ME Impact and management of skin toxicity associated with anti-epidermal growth factor receptor therapy: survey results. Oncology 2007;72 (3-4) 152- 159
PubMed
9 +
Lacouture  MEBasti  SPatel  JBenson  A  III The SERIES clinic: an interdisciplinary approach to the management of toxicities of EGFR inhibitors. J Support Oncol 2006;4 (5) 236- 238
PubMed

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

Submit a Letter
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Clear Answers | Save For Later
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Papulopustular Eruptions in a 32-Year-Old Woman After Lung Cancer Treatment—Quiz Case
Arch Dermatol. 2011;147(6):735-740. doi:10.1001/archdermatol.2011.127-a.
Topical Tretinoin, Lung Cancer, and Lung-Related Mortality
Arch Dermatol. 2008;144(7):945-946. doi:10.1001/archderm.144.7.945.
Related Topics
PubMed Articles
[Driver gene mutation and targeted therapy of lung cancer].
Gan To Kagaku Ryoho 2013;;40(3):285-90.
Comparison of Direct Sequencing, PNA Clamping-Real Time Polymerase Chain Reaction, and Pyrosequencing Methods for the Detection of EGFR Mutations in Non-small Cell Lung Carcinoma and the Correlation with Clinical Responses to EGFR Tyrosine Kinase Inhibitor Treatment.
Korean J Pathol 2013;;47(1):52-60.
Jobs

More Listings at
JAMACareerCenter.com >

© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems